These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38342436)

  • 1. Loss of function and reduced levels of sphingolipid desaturase DEGS1 variants are both relevant in disease mechanism.
    Dei Cas M; Montavoci L; Pasini C; Caretti A; Penati S; Martinelli C; Gianelli U; Casati S; Nardecchia F; Torella A; Brunetti-Pierri N; Trinchera M
    J Lipid Res; 2024 Mar; 65(3):100517. PubMed ID: 38342436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare
    Blackburn NB; Michael LF; Meikle PJ; Peralta JM; Mosior M; McAhren S; Bui HH; Bellinger MA; Giles C; Kumar S; Leandro AC; Almeida M; Weir JM; Mahaney MC; Dyer TD; Almasy L; VandeBerg JL; Williams-Blangero S; Glahn DC; Duggirala R; Kowala M; Blangero J; Curran JE
    J Lipid Res; 2019 Sep; 60(9):1630-1639. PubMed ID: 31227640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihydroceramide desaturase regulates the compartmentalization of Rac1 for neuronal oxidative stress.
    Tzou FY; Su TY; Lin WS; Kuo HC; Yu YL; Yeh YH; Liu CC; Kuo CH; Huang SY; Chan CC
    Cell Rep; 2021 Apr; 35(2):108972. PubMed ID: 33852856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The atypical sphingolipid SPB 18:1(14Z);O2 is a biomarker for DEGS1 related hypomyelinating leukodystrophy.
    Hülsmeier AJ; Toelle SP; Bellstedt P; Wentzel C; Bahr A; Kolokotronis K; Hornemann T
    J Lipid Res; 2023 Dec; 64(12):100464. PubMed ID: 37890668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydroceramide desaturase 1, the gatekeeper of ceramide induced lipotoxicity.
    Rodriguez-Cuenca S; Barbarroja N; Vidal-Puig A
    Biochim Biophys Acta; 2015 Jan; 1851(1):40-50. PubMed ID: 25283058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydroceramide Δ4-Desaturase 1 Is Not Involved in SARS-CoV-2 Infection.
    Hayashi Y; Matsuda K; Tanigawa K; Tanikawa T; Maeda K; Tsuchiya K
    Biol Pharm Bull; 2022; 45(10):1559-1563. PubMed ID: 36184516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingolipid desaturase DEGS1 is essential for mitochondria-associated membrane integrity.
    Planas-Serra L; Launay N; Goicoechea L; Heron B; Jou C; Juliá-Palacios N; Ruiz M; Fourcade S; Casasnovas C; De La Torre C; Gelot A; Marsal M; Loza-Alvarez P; García-Cazorla À; Fatemi A; Ferrer I; Portero-Otin M; Area-Gómez E; Pujol A
    J Clin Invest; 2023 May; 133(10):. PubMed ID: 36951944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DEGS1 -related leukodystrophy: a clinical report and review of literature.
    Wong MST; Thomas T; Lim JY; Kam S; Teo JX; Ching J; Goh CYJ; Jamuar SS; Lim WK; Koh AL
    Clin Dysmorphol; 2023 Jul; 32(3):106-111. PubMed ID: 37195341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma-tocotrienol profoundly alters sphingolipids in cancer cells by inhibition of dihydroceramide desaturase and possibly activation of sphingolipid hydrolysis during prolonged treatment.
    Jang Y; Rao X; Jiang Q
    J Nutr Biochem; 2017 Aug; 46():49-56. PubMed ID: 28456081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydroceramide Desaturase Functions as an Inducer and Rectifier of Apoptosis: Effect of Retinol Derivatives, Antioxidants and Phenolic Compounds.
    Alsanafi M; Brown RDR; Oh J; Adams DR; Torta F; Pyne NJ; Pyne S
    Cell Biochem Biophys; 2021 Sep; 79(3):461-475. PubMed ID: 33991313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevation of fatty acid desaturase 2 in esophageal adenocarcinoma increases polyunsaturated lipids and may exacerbate bile acid-induced DNA damage.
    Molendijk J; Kolka CM; Cairns H; Brosda S; Mohamed A; Shah AK; Brown I; Hodson MP; Hennessy T; Liu G; Stoll T; Richards RS; Gartside M; Patel K; Clemons NJ; Phillips WA; Barbour A; Westerhuis JA; Hill MM
    Clin Transl Med; 2022 May; 12(5):e810. PubMed ID: 35560527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathophysiological role of dihydroceramide desaturase in the nervous system.
    Tzou FY; Hornemann T; Yeh JY; Huang SY
    Prog Lipid Res; 2023 Jul; 91():101236. PubMed ID: 37187315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydroceramide desaturase knockdown impacts sphingolipids and apoptosis after photodamage in human head and neck squamous carcinoma cells.
    Breen P; Joseph N; Thompson K; Kraveka JM; Gudz TI; Li L; Rahmaniyan M; Bielawski J; Pierce JS; VAN Buren E; Bhatti G; Separovic D
    Anticancer Res; 2013 Jan; 33(1):77-84. PubMed ID: 23267130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased dihydroceramide/ceramide ratio mediated by defective expression of degs1 impairs adipocyte differentiation and function.
    Barbarroja N; Rodriguez-Cuenca S; Nygren H; Camargo A; Pirraco A; Relat J; Cuadrado I; Pellegrinelli V; Medina-Gomez G; Lopez-Pedrera C; Tinahones FJ; Symons JD; Summers SA; Oresic M; Vidal-Puig A
    Diabetes; 2015 Apr; 64(4):1180-92. PubMed ID: 25352638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of the sphingolipid desaturase DEGS1 causes hypomyelinating leukodystrophy.
    Pant DC; Dorboz I; Schluter A; Fourcade S; Launay N; Joya J; Aguilera-Albesa S; Yoldi ME; Casasnovas C; Willis MJ; Ruiz M; Ville D; Lesca G; Siquier-Pernet K; Desguerre I; Yan H; Wang J; Burmeister M; Brady L; Tarnopolsky M; Cornet C; Rubbini D; Terriente J; James KN; Musaev D; Zaki MS; Patterson MC; Lanpher BC; Klee EW; Pinto E Vairo F; Wohler E; Sobreira NLM; Cohen JS; Maroofian R; Galehdari H; Mazaheri N; Shariati G; Colleaux L; Rodriguez D; Gleeson JG; Pujades C; Fatemi A; Boespflug-Tanguy O; Pujol A
    J Clin Invest; 2019 Mar; 129(3):1240-1256. PubMed ID: 30620337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydroceramide desaturase and dihydrosphingolipids: debutant players in the sphingolipid arena.
    Fabrias G; Muñoz-Olaya J; Cingolani F; Signorelli P; Casas J; Gagliostro V; Ghidoni R
    Prog Lipid Res; 2012 Apr; 51(2):82-94. PubMed ID: 22200621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DEGS1-associated aberrant sphingolipid metabolism impairs nervous system function in humans.
    Karsai G; Kraft F; Haag N; Korenke GC; Hänisch B; Othman A; Suriyanarayanan S; Steiner R; Knopp C; Mull M; Bergmann M; Schröder JM; Weis J; Elbracht M; Begemann M; Hornemann T; Kurth I
    J Clin Invest; 2019 Mar; 129(3):1229-1239. PubMed ID: 30620338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DEGS1 variant causes neurological disorder.
    Dolgin V; Straussberg R; Xu R; Mileva I; Yogev Y; Khoury R; Konen O; Barhum Y; Zvulunov A; Mao C; Birk OS
    Eur J Hum Genet; 2019 Nov; 27(11):1668-1676. PubMed ID: 31186544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of dihydroceramide desaturase drives neurodegeneration by disrupting endoplasmic reticulum and lipid droplet homeostasis in glial cells.
    Zhu Y; Cho K; Lacin H; Zhu Y; DiPaola JT; Wilson BA; Patti GJ; Skeath JB
    bioRxiv; 2024 May; ():. PubMed ID: 38260379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Native and Polyubiquitinated Forms of Dihydroceramide Desaturase Are Differentially Linked to Human Embryonic Kidney Cell Survival.
    Alsanafi M; Kelly SL; Jubair K; McNaughton M; Tate RJ; Merrill AH; Pyne S; Pyne NJ
    Mol Cell Biol; 2018 Dec; 38(23):. PubMed ID: 30224516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.